Prof. Dr. Martin Fromm

Lehrstuhl für Klinische Pharmakologie und Klinische Toxikologie

Drug Therapy Safety with new oral Antitumor Agents for the Therapy of Prostate and Renal Cell Carcinoma: Findings from the AMBORA Study (2022) Cuba L, Schlichtig K, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Conference contribution MATE1 Deficiency Exacerbates Dofetilide-Induced Proarrhythmia (2022) Uddin ME, Eisenmann ED, Li Y, Huang KM, Garrison DA, Talebi Z, Gibson AA, et al. Journal article New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial (2022) Schlichtig K, Cuba L, Dürr P, Bellut L, Meidenbauer N, Kunath F, Goebell P, et al. Journal article Arzneimittelmerkblätter und weitere Informationsmaterialien bei oraler Tumortherapie (2022) Dörje F, Fromm M Journal article Comprehensibility of Contraindications in German, UK and US Summaries of Product Characteristics/Prescribing Information-A Comparative Qualitative and Quantitative Analysis (2022) Then M, Andrikyan W, Fromm M, Maas R Journal article Renal Transporter-Mediated Drug-Biomarker Interactions of the Endogenous Substrates Creatinine and N-1-Methylnicotinamide: A PBPK Modeling Approach (2022) Tuerk D, Müller F, Fromm M, Selzer D, Dallmann R, Lehr T Journal article Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022) Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al. Conference contribution Improved, but still limited coding of medication-related problems - application of the new WHO ICD-11 code-set to clinical routine data (2022) Jung-Poppe L, Andrikyan W, Altenbuchner A, Pfistermeister B, Dormann H, Fromm M, Maas R Conference contribution Development and validation of an LC-MS method for drug exposure measurement of 57 oral antitumor drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution Inconsistencies and Ambiguities in Liver-Disease-Related Contraindications—A Systematic Analysis of SmPCs/PI of Major Drug Markets (2022) Weisbach L, Schuster AK, Hartmann M, Fromm M, Maas R, Farker K Journal article